⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADIL News
Adial Pharmaceuticals, Inc
Form 8-K
sec.gov
ADIL
Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement
globenewswire.com
ADIL
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
globenewswire.com
ADIL
Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
ADIL
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
globenewswire.com
ADIL
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
globenewswire.com
ADIL
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
globenewswire.com
ADIL
Acclaimed Neuropsychiatrist Professor Dr. Bankole A. Johnson Releases "When Dragons Kill" - A Forbes News-Ranked Psychological Fiction Masterpiece Exploring the Hidden Darkness Within Human Nature
accessnewswire.com
ADIL
Acclaimed Neuropsychiatrist Professor Dr. Bankole A. Johnson Releases "When Dragons Kill" - A Forbes News-Ranked Psychological Fiction Masterpiece Exploring the Hidden Darkness Within Human Nature
accessnewswire.com
ADIL
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
globenewswire.com
ADIL